Erik Sahai, Group leader

Erik Sahai

Principal Group Leader - Assistant Research Director

Erik obtained his PhD with Richard Treisman in London studying RhoGTPases and their effectors. He then carried out post-doctoral work in both London (Chris Marshall) and New York (John Condeelis) before setting up his own group at the Cancer Research UK London Research Institute in 2004 (now part of the Francis Crick Institute).

Qualifications and history

1998
University College, London, UK
PhD in Biochemistry
1998
Institute of Cancer Research, UK
Postdoctoral Fellow
2003
Albert Einstein College of Medicine, USA
Postdoctoral Fellow
2004
London Research Institute, Cancer Research UK
Established lab
2015
Francis Crick Institute
Group Leader

Crick Pre-Crick

Journal

Displaying 1 - 20 of 126
Last updated : 03 March 2026 02:52

Multicellular calcium waves in cancer-associated fibroblasts regulate neuronal mimicry and anisotropy leading to immune exclusion

Preprint
Authors (20)
bioRxiv
Published
Crick labs/ facilities
Full details

Inhibition of neutrophil degranulation by Nexinhib20 delays the development of radiation-induced pulmonary fibrosis

Preprint
Authors (9)
bioRxiv
Published
Crick labs/ facilities
Full details

Rapid expansion of podoplanin-positive fibroblasts following radiation limits the anti-tumour CD8+ T-cell response to radiotherapy

Preprint
Authors (23)
bioRxiv
Published
Crick labs/ facilities
Full details

Splenic granulopoiesis and S100A9 drive resistance to checkpoint inhibitors conferred by liver metastases

Preprint
Authors (27)
bioRxiv
Published
Crick labs/ facilities
Full details

Spatial organisation of tumour cDC1 states correlates with effector and stem-like CD8+ T cells location

Authors (14)
European Journal of Immunology
Published
Crick labs/ facilities
Full details

Multimodal profiling unveils a reversible breast basal-like cell state in AKT-inhibitor resistant tumours

Preprint
Authors (29)
bioRxiv
Published
Crick labs/ facilities
Full details